To evaluate the safety and tolerability of LY3437943, a randomized, double-blind, placebo-controlled Phase 1 clinical trial was conducted on 45 healthy subjects
Loss of Muscle Mass: Ongoing calorie restriction may result in loss of muscle mass which will be detrimental to overall health and maintaining weight loss after discontinuation
Summary: Fuel workouts on GLP-1 medications by prioritising protein intake (1.21.6g/kg daily), timing meals 23 hours before exercise, choosing easily digestible carbohydrates, and using liquid nutrition when appetite is suppressed
Tracking your progress through the dose schedule A structured tracking system helps you make informed decisions about dose escalation timing and identifies patterns that optimize your protocol
For detailed conversion calculations, the retatrutide dosage calculator can help determine exact split dosing amounts based on your total weekly target and chosen frequency
Ultimately, the success of microdosing GLP-1s hinges on clinical oversight and data-driven personalization